疫苗接种行为相关性对老年人COVID-19疫苗有效性估计的影响
本研究基于VISION电子健康记录平台,采用检测阴性设计,评估2023-2024呼吸道病毒季节老年人COVID-19疫苗有效性。通过不同方法处理COVID-19、流感及RSV疫苗接种状态间的潜在相关性,发现接种后≥7天,针对急诊/紧急护理就诊和住院的VE估计变化分别不超过5和3个百分点。
要点
- 考虑流感/RSV接种状态或排除其阳性对照后,COVID-19 VE估计变化有限。
- 针对ED/UC就诊的VE估计增加≤5个百分点,住院VE增加≤3个百分点。
- 该影响程度取决于季节特异性因素,需持续监测。
核心结论
- 在检测阴性设计中,忽略疫苗接种行为相关性对2023-2024 COVID-19 VE估计的影响较小。
主要发现
- 接种后≥7天,针对COVID-19相关ED/UC就诊的VE估计在不同方法间差异不超过5个百分点。
- 针对COVID-19相关住院的VE估计差异不超过3个百分点。
关键数值与推荐
- 考虑流感/RSV接种状态或排除流感/RSV阳性对照时,VE估计变化幅度如上。
临床怎么用
- 在估计COVID-19疫苗有效性时,需考虑流感/RSV接种行为相关性,但本研究中影响有限。
- 持续监测季节特异性因素对VE估计的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Test negative design studies allow for COVID-19 vaccine effectiveness (VE) estimation while minimizing selection bias from healthcare seeking and testing practices. However, failure to consider correlation between vaccination behaviors may result in biased COVID-19 VE estimates. Using different methods to account for potential correlation between COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination status, we investigated variability in VE estimates of the 2023-2024 COVID-19 vaccine against COVID-19-associated emergency department and urgent care (ED/UC) encounters and hospitalizations during the 2023-2024 respiratory virus season. Data were leveraged from VISION, an electronic health record-based platform. VE estimates ≥7 days post vaccination did not increase by more than 5 percentage points against ED/UC encounters and 3 percentage points against hospitalizations when accounting for influenza and RSV vaccination status or excluding influenza and RSV positive controls. As the magnitude of this influence depends on season-specific factors, ongoing monitoring is warranted.
引用
- Kautz A, Yang DH, Chickery S, et al. Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. Vaccine. 2026. PMID: 42391690. doi:10.1016/j.vaccine.2026.128891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。